We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Advises Manufacturers on Marketing Requirements
EMEA Advises Manufacturers on Marketing Requirements
September 17, 2009
Drugmakers that plan to market their products in Norway, Iceland and Liechtenstein must provide authorities in those countries with mock-ups of all product presentations at least a month before sales are scheduled to begin, the European Medicines Agency (EMEA) says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor